Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

The causal role of human papillomavirus infections in cervical cancer has been documented
beyond reasonable doubt. The association is present in virtually all cervical cancer cases …

Early detection represents one of the most promising approaches to reducing the growing
cancer burden. It already has a key role in the management of cervical and breast cancer …

This chapter suggests promising areas of future epidemiologic research on human
papillomavirus (HPV) and anogenital cancer, organized around our understanding of …

Human papillomavirus (HPV)-related screening technologies and HPV vaccination offer
enormous potential for cancer prevention, notably prevention of cervical cancer. The …

Abstract Each year the American Cancer Society publishes a summary of existing
recommendations for early cancer detection, including updates, and/or emerging issues that …

PURPOSE: Global data on age-specific prevalence of human papillomavirus (HPV) infection
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …

Human papillomavirus (HPV) can be detected by amplification of viral DNA. A novel PCR
primer set generating a short PCR fragment (SPF PCR) was used for amplification of a …

Background The aim of this study was to assess the probability of low-grade squamous intra-
epithelial lesion (LSIL) regression in young women, and to examine the factors associated …

A novel set of polymerase chain reaction (PCR) primers, designated SPF1 and SPF2 and
located in the L1 region, was developed for universal detection of human papillomavirus …